KODIAK SCIENCES INC. Common Stock, Capital Shares Reserved for Future Issuance
KODIAK SCIENCES INC. (KOD) had Common Stock, Capital Shares Reserved for Future Issuance of 23.26 million shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-31
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 23.26M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 22.18M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.60M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 19.18M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 23.26M shares 10-K · filed 2026-03-31 |
| 2024-12-31 | 22.18M shares 10-K · filed 2025-03-27 |
| 2023-12-31 | 20.60M shares 10-K · filed 2025-03-27 |
| 2022-12-31 | 19.18M shares 10-K · filed 2024-03-28 |
| 2021-12-31 | 17.69M shares 10-K · filed 2023-03-28 |
| 2020-12-31 | 10.86M shares 10-K · filed 2022-03-01 |
| 2019-12-31 | 9.81M shares 10-K · filed 2021-03-01 |
| 2018-12-31 | 9.02M shares 10-K · filed 2020-03-16 |
| 2017-12-31 | 16.85M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |